article thumbnail

Influencing Factors of Adherence Dynamics in Young Adults with Hypertension: A Mixed-Methods Study [Hypertension]

Annals of Family Medicine

Context Young adults with hypertension are a susceptible group prone to changes in adherence influenced by external factors, which are associated with lower control rates and adverse long-term prognoses. However, the factors influencing the dynamics of adherence among young Chinese patients with hypertension remain unclear.

article thumbnail

Evaluating the Impact of Data Visualization with China-PAR on Hypertension Management in Primary Care: A Pilot Study [Hypertension]

Annals of Family Medicine

Although data visualization is gaining traction in the hypertension, its use in health education and information dissemination is still underutilized. Objective This study aims to investigate the impact of data visualization using China-PAR on managing hypertension among primary care patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Population Studied individuals with comorbidity of hypertension and type 2 diabetes. Outcome Measures Changes of China-PAR score and cardiovascular hospitalization events.

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. “I am very excited and pleased to have Widaplik approved for the treatment of hypertension in the U.S. WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. All rights reserved.

article thumbnail

Hypertension with Dr. Nina Vasavada

Louisville Lectures

Nina Vasavada presents Hypertension by first discussing a general approach to ambulatory patients with elevated blood pressure. She then presents primary versus secondary hypertension, and ends her discussion on hypertension management in special populations. Her clinical expertise is in Nephrology as well as Hypertension.

article thumbnail

Overall medication adherence as an indicator for health outcomes among elderly patients with hypertension and diabetes [Diabetes and endocrine disease]

Annals of Family Medicine

Objectives To assess overall medication adherence as an indicator for emergency room (ER) visits, hospitalizations, and mortality among elderly patients. Methods The study included individuals aged 75 to 90 years, diagnosed with diabetes or hypertension, who were treated with at least one antihypertensive, or antidiabetic medication in 2017.

article thumbnail

Intensity of medication review activities in private and public clinics [Prescribing and pharmacotherapeutics]

Annals of Family Medicine

Setting: One private primary care clinic and two clinics of a safety net hospital system that serves inner-city populations with significant socio-economic challenges. vs 28.2%), numbers of prescription medications (6[5;9] vs 6 [5;8]), and prevalent conditions requiring medications, including hypertension (81.5 vs 96.1%).

Clinic 130